NAD+

nicotinamide adenine dinucleotide

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NAD+, covering 2023-01-25 to 2025-08-05. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia [Phase 1, Phase 2]